Flowmod, Inc.
Clinical trials sponsored by Flowmod, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- An evaluation of the FLOWMod system to occlude vena cava blood flow in subjects with acute decompensated heart failure Results expected Feb 2027 (estimated)